Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "new-drug development"
Home
Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27
Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's Ministry of Food and Drug Safety...
08/13/2026, 11:04 ET
South Korea to Deploy AI Across Public Health Centers and Ambulances to Close Care Gaps
Artificial intelligence tools that assist in interpreting X-ray images and drafting clinical notes will soon be deployed to public health centers in...
08/09/2026, 11:04 ET
From Retinal Scans to Brain Imaging: South Korea Backs Six Medical AI Tools for Fast-Track Hospital Adoption
Medical AI tools designed to assess cardiovascular risk from retinal images and analyze brain scans for stroke severity...
08/09/2026, 10:45 ET
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care
Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.
08/03/2026, 09:55 ET
AI Platform Replaces Animal Models to Accelerate Parkinson’s Cell Therapy
Researchers are launching an international joint study that leverages artificial intelligence to evaluate whether...
08/01/2026, 04:21 ET
South Korea Overhauls Pharma and Biotech Disclosure Rules Following Samchundang Controversy
South Korean financial authorities are overhauling disclosure regulations across the pharmaceutical and biotechnology...
07/31/2026, 09:56 ET
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%
Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
07/31/2026, 04:21 ET
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short
Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
07/28/2026, 08:34 ET
Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead
Biogen Korea has appointed Kim Chul-woong as its new general manager, tapping an executive with extensive expertise in...
07/26/2026, 08:04 ET
Unlocking the Mystery of Bladder Pain: Researchers Map Cellular Network Driving Interstitial Cystitis
Sharp, stinging pelvic pain and dozens of exhausting trips to the bathroom in a single day—these are the debilitating...
07/20/2026, 19:27 ET
Previous
1
2
3
4
Next